Yoo Christine B, Jones Peter A
USC/Norris Comprehensive Cancer Center, Department of Urology, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, California 90089, USA.
Nat Rev Drug Discov. 2006 Jan;5(1):37-50. doi: 10.1038/nrd1930.
The initiation and progression of cancer is controlled by both genetic and epigenetic events. Unlike genetic alterations, which are almost impossible to reverse, epigenetic aberrations are potentially reversible, allowing the malignant cell population to revert to a more normal state. With the advent of numerous drugs that target specific enzymes involved in the epigenetic regulation of gene expression, the utilization of epigenetic targets is emerging as an effective and valuable approach to chemotherapy as well as chemoprevention of cancer.
癌症的发生和发展受遗传和表观遗传事件的控制。与几乎无法逆转的基因改变不同,表观遗传异常具有潜在的可逆性,可使恶性细胞群体恢复到更正常的状态。随着众多靶向参与基因表达表观遗传调控的特定酶的药物问世,利用表观遗传靶点正成为一种有效且有价值的癌症化疗及化学预防方法。